# Verification & Validation Plan — Burn Wizard

**Document:** Verification & Validation Plan  
**Version:** 1.0  
**Owner:** Perry Martin  
**Location:** `/docs/V&V_PLAN.md`  
**Date:** 2025-08-18  
**Status:** Active

---

## Document Control

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 1.0 | 2025-08-18 | Perry Martin | Initial V&V plan aligned with SRS and regulatory requirements |

---

## Table of Contents

1. [Introduction](#1-introduction)
2. [V&V Strategy](#2-vv-strategy)
3. [Verification Plan](#3-verification-plan)
4. [Validation Plan](#4-validation-plan)
5. [Test Environment](#5-test-environment)
6. [Acceptance Criteria](#6-acceptance-criteria)
7. [Risk-Based Testing](#7-risk-based-testing)
8. [Traceability Matrix](#8-traceability-matrix)
9. [Test Schedule](#9-test-schedule)
10. [Deliverables](#10-deliverables)

---

## 1. Introduction

### 1.1 Purpose

This Verification & Validation (V&V) Plan defines the systematic approach for demonstrating that Burn Wizard meets its specified requirements (verification) and fulfills its intended use in clinical educational settings (validation).

### 1.2 Scope

**Verification Scope:**
- All functional requirements defined in SRS
- Non-functional requirements (performance, security, usability)
- Domain logic accuracy against clinical references
- Software architecture compliance

**Validation Scope:**
- Clinical workflow suitability
- Educational effectiveness
- User safety and error prevention
- Real-world deployment readiness

### 1.3 Definitions

| Term | Definition |
|------|------------|
| **Verification** | Confirmation that software requirements have been fulfilled through objective evidence |
| **Validation** | Confirmation that requirements for intended use have been fulfilled |
| **IQ** | Installation Qualification - verification of proper installation |
| **OQ** | Operational Qualification - verification of operational functionality |
| **PQ** | Performance Qualification - validation of performance in intended environment |

### 1.4 Regulatory Context

This V&V plan supports:
- ISO 14971 risk management compliance
- Medical device software development best practices
- Institutional deployment validation requirements
- Clinical safety and educational positioning verification

---

## 2. V&V Strategy

### 2.1 V-Model Implementation

```
Requirements → System Testing
    ↓             ↑
Architecture → Integration Testing  
    ↓             ↑
Detailed Design → Unit Testing
    ↓             ↑
Implementation → Code Review
```

### 2.2 Risk-Based Approach

Testing priorities based on Risk Register:
- **High Priority:** Calculation accuracy (RR-001, RR-002)
- **High Priority:** Data security (RR-004, RR-006)
- **Medium Priority:** UI usability (RR-005, RR-014)
- **Low Priority:** Performance optimization

### 2.3 Multi-Level Testing Strategy

#### Level 1: Unit Testing
- **Coverage:** 100% for domain modules
- **Focus:** Pure function verification, boundary conditions
- **Tools:** Vitest, TypeScript strict mode
- **Automation:** CI/CD pipeline integration

#### Level 2: Integration Testing
- **Coverage:** Component interactions, data flow
- **Focus:** UI-domain integration, offline functionality
- **Tools:** Vitest integration tests, PWA testing
- **Environment:** Simulated clinical scenarios

#### Level 3: System Testing
- **Coverage:** Complete application workflows
- **Focus:** End-to-end scenarios, performance validation
- **Tools:** Manual testing, automated E2E framework
- **Environment:** Production-like deployment

#### Level 4: User Acceptance Testing
- **Coverage:** Clinical workflow validation
- **Focus:** Real user scenarios, safety verification
- **Tools:** Clinical SME review, usability studies
- **Environment:** Pilot deployment sites

---

## 3. Verification Plan

### 3.1 Requirements Verification

#### 3.1.1 Functional Requirements Verification

| Requirement ID | Verification Method | Test Specification | Pass Criteria |
|---|---|---|---|
| FR-001 | Automated Testing | Session CRUD operations | All operations succeed, data persists |
| FR-002 | Unit + Reference Testing | TBSA calculation validation | ±0.1% accuracy vs Lund-Browder |
| FR-003 | Unit + Clinical Testing | Parkland formula validation | Exact match to published examples |
| FR-004 | Manual Testing | Mode switching verification | Correct UI adaptation, no data loss |
| FR-005 | Integration Testing | Export functionality | Complete notes, proper formatting |
| FR-006 | Security Testing | Encryption verification | AES-256 implementation confirmed |
| FR-007 | Automated Testing | Audit trail validation | All events logged with timestamps |

#### 3.1.2 Non-Functional Requirements Verification

| Requirement ID | Verification Method | Test Specification | Pass Criteria |
|---|---|---|---|
| NFR-001 | Performance Testing | Response time measurement | <100ms for calculations |
| NFR-004 | Offline Testing | Network disconnection tests | 30+ minutes full functionality |
| NFR-007 | Security Testing | Encryption verification | All data encrypted at rest |
| NFR-010 | Usability Testing | Task completion analysis | >80% success rate |
| NFR-013 | Code Review | TypeScript compliance | 100% strict mode compliance |

### 3.2 Domain Logic Verification

#### 3.2.1 TBSA Calculation Verification

**Test Specification: V-TBSA-001**
- **Objective:** Verify Lund-Browder implementation accuracy
- **Method:** Unit testing against published reference values
- **Test Cases:** 
  - Age boundary testing (exact transitions)
  - Regional percentage validation across age groups
  - Fractional involvement calculations
  - Edge cases (minimum/maximum scenarios)
- **Pass Criteria:** All calculations within ±0.1% of reference values

**Clinical Reference Cases:**
```typescript
// Infant (6 months) head burn
calcTbsa(6, [{region: 'Head', fraction: 1}]) === 19%

// Adult (25 years) trunk burn  
calcTbsa(300, [{region: 'Ant_Trunk', fraction: 1}]) === 13%

// Age progression validation
Head percentages: 19% → 17% → 13% → 11% → 9% → 7%
```

#### 3.2.2 Fluid Calculation Verification

**Test Specification: V-FLUID-001**
- **Objective:** Verify Parkland formula implementation
- **Method:** Unit testing against clinical examples
- **Test Cases:**
  - Standard Parkland calculations
  - Temporal adjustment verification
  - Maintenance fluid (4-2-1 rule) validation
  - Edge cases (minimum weight, maximum TBSA)
- **Pass Criteria:** Exact match to published clinical examples

**Clinical Reference Cases:**
```typescript
// Standard adult case
calcFluids({weightKg: 70, tbsaPct: 30, hoursSinceInjury: 0})
// Expected: 8400ml total, 4200ml first 8h, 525ml/hr rate

// Pediatric case with temporal adjustment
calcFluids({weightKg: 20, tbsaPct: 20, hoursSinceInjury: 2})
// Expected: 1600ml total, 600ml remaining, 100ml/hr rate
```

### 3.3 Architecture Verification

#### 3.3.1 Code Quality Verification

**Test Specification: V-CODE-001**
- **Objective:** Verify code quality standards
- **Method:** Automated code analysis
- **Verification Points:**
  - TypeScript strict mode compliance
  - ESLint rule adherence
  - Pure function implementation (domain modules)
  - Import/export structure correctness
- **Tools:** TypeScript compiler, ESLint, automated CI checks

#### 3.3.2 Security Implementation Verification

**Test Specification: V-SEC-001**
- **Objective:** Verify security implementation
- **Method:** Security testing and code review
- **Verification Points:**
  - AES-256 encryption implementation
  - PIN authentication functionality
  - Audit logging completeness
  - Data wiping capabilities
- **Tools:** Security testing framework, manual verification

---

## 4. Validation Plan

### 4.1 Clinical Workflow Validation

#### 4.1.1 Emergency Department Scenario Validation

**Test Specification: VAL-ED-001**
- **Objective:** Validate ED workflow suitability
- **Method:** Clinical SME review and simulation
- **Scenario:** Pediatric patient with scalding injury
- **Participants:** ED nurses, residents, attending physicians
- **Duration:** 2-hour simulation session
- **Success Criteria:**
  - >80% task completion without assistance
  - <5 minutes total calculation time
  - Accurate clinical note generation
  - Positive usability feedback

#### 4.1.2 Outpatient Clinic Validation

**Test Specification: VAL-CLINIC-001**
- **Objective:** Validate clinic workflow integration
- **Method:** Real-world pilot testing
- **Scenario:** Follow-up burn assessment and documentation
- **Participants:** Burn clinic staff
- **Duration:** 2-week pilot period
- **Success Criteria:**
  - Integration with existing workflows
  - Documentation quality improvement
  - Time efficiency gains
  - Clinical accuracy maintenance

### 4.2 Educational Effectiveness Validation

#### 4.2.1 Patient Education Mode Validation

**Test Specification: VAL-PATIENT-001**
- **Objective:** Validate patient education effectiveness
- **Method:** Patient/family testing with comprehension assessment
- **Participants:** Volunteer patients/families (n=10)
- **Validation Points:**
  - Information comprehension rate
  - Anxiety reduction assessment
  - Action plan understanding
  - Satisfaction with educational content
- **Success Criteria:** >70% comprehension rate, positive feedback

#### 4.2.2 Clinical Training Validation

**Test Specification: VAL-TRAIN-001**
- **Objective:** Validate training effectiveness for clinical staff
- **Method:** Before/after knowledge assessment
- **Participants:** Nursing staff and residents (n=20)
- **Validation Points:**
  - Burn assessment accuracy improvement
  - Fluid calculation confidence increase
  - Time to competency reduction
  - Educational value perceived
- **Success Criteria:** >15% improvement in assessment accuracy

### 4.3 Safety Validation

#### 4.3.1 Error Prevention Validation

**Test Specification: VAL-SAFETY-001**
- **Objective:** Validate error prevention mechanisms
- **Method:** Usability testing with error injection
- **Test Cases:**
  - Invalid input handling
  - Mode confusion prevention
  - Educational disclaimer effectiveness
  - Recovery from user errors
- **Success Criteria:** 
  - No safety-critical errors undetected
  - 100% educational disclaimer display
  - <5% mode confusion incidents

#### 4.3.2 Real-World Deployment Validation

**Test Specification: VAL-DEPLOY-001**
- **Objective:** Validate deployment readiness
- **Method:** Pilot installation at clinical site
- **Duration:** 4-week pilot deployment
- **Validation Points:**
  - IT infrastructure compatibility
  - User adoption rate
  - System reliability
  - Clinical workflow integration
- **Success Criteria:**
  - >95% uptime
  - >60% user adoption
  - Zero safety incidents
  - Positive IT feedback

---

## 5. Test Environment

### 5.1 Development Environment

**Purpose:** Unit and integration testing
**Configuration:**
- Local development machines
- Node.js 18+ with TypeScript 5+
- Vitest testing framework
- Chrome DevTools for PWA testing

### 5.2 Staging Environment

**Purpose:** System testing and pre-deployment validation
**Configuration:**
- Production-like server setup
- HTTPS configuration
- Offline simulation capabilities
- Performance monitoring tools

### 5.3 Pilot Environment

**Purpose:** Clinical validation and user acceptance testing
**Configuration:**
- Clinical site deployment
- Real network conditions
- Multiple device types (desktop, tablet, mobile)
- Clinical workflow integration

### 5.4 Test Data Management

#### 5.4.1 Synthetic Test Data

**Clinical Reference Cases:**
- Age boundary test cases (exact month transitions)
- Regional percentage validation data
- Parkland formula reference calculations
- Error condition test scenarios

**Data Sources:**
- Published Lund-Browder tables
- Clinical literature examples
- Validated calculation worksheets
- Edge case synthetic data

#### 5.4.2 Privacy Protection

**PHI Handling:**
- No real patient data in testing
- Synthetic patient scenarios only
- GDPR/HIPAA compliant test data
- Secure test data disposal

---

## 6. Acceptance Criteria

### 6.1 Verification Acceptance Criteria

#### 6.1.1 Functional Acceptance
- [ ] All FR requirements pass specified tests
- [ ] Domain calculations accurate to ±0.1%
- [ ] Security implementation verified
- [ ] Performance targets met (<100ms calculations)
- [ ] Offline functionality reliable (30+ minutes)

#### 6.1.2 Code Quality Acceptance
- [ ] 100% unit test coverage for domain modules
- [ ] TypeScript strict mode compliance
- [ ] Zero high-severity security vulnerabilities
- [ ] ESLint compliance with medical-specific rules
- [ ] Documentation completeness verified

### 6.2 Validation Acceptance Criteria

#### 6.2.1 Clinical Acceptance
- [ ] >80% task completion rate in clinical scenarios
- [ ] Positive clinical SME review and sign-off
- [ ] Educational effectiveness demonstrated
- [ ] Safety validation successful
- [ ] Workflow integration confirmed

#### 6.2.2 Deployment Acceptance
- [ ] Pilot deployment successful
- [ ] IT infrastructure compatibility confirmed
- [ ] User training materials validated
- [ ] Support documentation complete
- [ ] Regulatory compliance verified

---

## 7. Risk-Based Testing

### 7.1 High-Risk Areas (Critical Testing)

#### RR-001: Incorrect TBSA Calculation
**Testing Strategy:**
- Comprehensive unit testing with reference validation
- Boundary condition testing for age transitions
- Multiple clinical reviewer verification
- Automated regression testing in CI pipeline

#### RR-002: Parkland Formula Miscalculation  
**Testing Strategy:**
- Reference case validation against published examples
- Temporal calculation verification
- Edge case testing (minimum/maximum values)
- Clinical SME mathematical review

#### RR-004: Data Security Breach
**Testing Strategy:**
- Penetration testing of encryption implementation
- Authentication mechanism verification
- Data wiping functionality testing
- Security audit by external expert

### 7.2 Medium-Risk Areas (Standard Testing)

#### RR-005: UI Misrepresentation
**Testing Strategy:**
- Visual regression testing
- Cross-browser compatibility testing
- Accessibility compliance verification
- User interface consistency validation

### 7.3 Low-Risk Areas (Basic Testing)

#### Performance and Documentation
**Testing Strategy:**
- Automated performance benchmarking
- Documentation review and validation
- Basic functional testing
- Standard quality assurance procedures

---

## 8. Traceability Matrix

| Requirement | Design | Implementation | Test Case | Validation | Risk Control |
|---|---|---|---|---|---|
| FR-002 | domain/tbsa.ts | calcTbsa() | V-TBSA-001 | VAL-ED-001 | RR-001 |
| FR-003 | domain/fluids.ts | calcFluids() | V-FLUID-001 | VAL-CLINIC-001 | RR-002 |
| FR-006 | security-simple.ts | SecurityManager | V-SEC-001 | VAL-DEPLOY-001 | RR-004 |
| NFR-001 | Pure functions | Domain modules | Performance tests | Clinical timing | RR-005 |
| NFR-004 | Service worker | PWA config | Offline tests | Real-world pilot | Network failure |

---

## 9. Test Schedule

### 9.1 Phase 1: Unit and Integration Testing (Week 1-2)

**Week 1:**
- [ ] Complete domain module unit testing
- [ ] Integration testing implementation
- [ ] Code quality verification
- [ ] Security implementation testing

**Week 2:**
- [ ] Performance testing
- [ ] Offline functionality verification
- [ ] Cross-browser compatibility testing
- [ ] Automated test suite completion

### 9.2 Phase 2: System and Usability Testing (Week 3-4)

**Week 3:**
- [ ] End-to-end workflow testing
- [ ] Clinical scenario validation
- [ ] Usability testing with target users
- [ ] Safety validation testing

**Week 4:**
- [ ] Pilot deployment preparation
- [ ] Clinical SME review and validation
- [ ] Final acceptance testing
- [ ] Documentation review and approval

### 9.3 Phase 3: Clinical Validation (Week 5-8)

**Week 5-6:**
- [ ] Pilot site deployment
- [ ] Clinical staff training
- [ ] Initial usage monitoring
- [ ] Feedback collection initiation

**Week 7-8:**
- [ ] Usage data analysis
- [ ] Clinical effectiveness assessment
- [ ] Final validation report
- [ ] Deployment readiness certification

---

## 10. Deliverables

### 10.1 Verification Deliverables

- [ ] **Unit Test Reports** - Complete test results with coverage metrics
- [ ] **Integration Test Reports** - Component interaction verification
- [ ] **Performance Test Reports** - Response time and reliability metrics
- [ ] **Security Test Reports** - Encryption and authentication verification
- [ ] **Code Quality Reports** - TypeScript compliance and static analysis

### 10.2 Validation Deliverables

- [ ] **Clinical Workflow Validation Report** - ED and clinic scenario results
- [ ] **Educational Effectiveness Report** - Patient and staff training assessment
- [ ] **Safety Validation Report** - Error prevention and recovery testing
- [ ] **Pilot Deployment Report** - Real-world usage and performance
- [ ] **User Acceptance Test Report** - Clinical SME review and approval

### 10.3 Regulatory Deliverables

- [ ] **V&V Summary Report** - Complete verification and validation summary
- [ ] **Traceability Matrix** - Requirements to test case mapping
- [ ] **Risk Control Verification** - Mitigation effectiveness demonstration
- [ ] **Clinical SME Sign-off** - Medical accuracy and safety approval
- [ ] **Deployment Certification** - Ready for institutional deployment

---

## 11. Test Execution Procedures

### 11.1 Test Case Documentation

**Standard Format:**
- Test Case ID
- Test Objective
- Prerequisites
- Test Steps (detailed)
- Expected Results
- Pass/Fail Criteria
- Actual Results
- Status and Notes

### 11.2 Defect Management

**Severity Classification:**
- **Critical:** Safety impact, calculation errors
- **High:** Functional failures, data loss
- **Medium:** Usability issues, performance problems
- **Low:** Cosmetic issues, documentation errors

**Resolution Process:**
1. Defect identification and documentation
2. Severity assignment and prioritization
3. Root cause analysis and fix development
4. Fix verification and regression testing
5. Clinical review for medical content changes

### 11.3 Test Data Integrity

**Data Management:**
- Synthetic test data only (no real PHI)
- Version-controlled test case data
- Reproducible test scenarios
- Secure test data disposal

---

## 12. Sign-off and Approval

### 12.1 Verification Sign-off

**Required Approvals:**
- [ ] Development Lead - Code quality and technical accuracy
- [ ] QA Lead - Test execution and coverage verification  
- [ ] Security Lead - Security implementation verification
- [ ] Project Lead - Requirements compliance confirmation

### 12.2 Validation Sign-off

**Required Approvals:**
- [ ] Clinical SME - Medical accuracy and safety validation
- [ ] Usability Lead - User experience and workflow validation
- [ ] IT Lead - Deployment and infrastructure validation
- [ ] Regulatory Lead - Compliance and documentation validation

### 12.3 Final Deployment Authorization

**Prerequisites:**
- All verification criteria met
- All validation criteria met
- Clinical SME approval obtained
- Risk assessment updated
- Training materials approved
- Support processes established

---

**Document Control:**
- **Last Updated:** 2025-08-18
- **Next Review:** 2025-09-18  
- **Approval Required:** Clinical SME, QA Lead, Project Lead
- **Distribution:** Development Team, Clinical Stakeholders, QA Team

**End of Verification & Validation Plan**